Sublocade modified release solution for injection Indivior Pty Ltd
Product name
Sublocade modified release solution for injection
Sponsor
Accepted date
Jan-2025
Active ingredients
buprenorphine
Proposed indication
SUBLOCADE is for the treatment of opioid dependence, in parallel with other medical, social and psychological treatment.
Application type
C (new indication)
Publication date
Jan-2025